Breaking
Friday, June 19, 2026

Oncology News

🌏 NMPA

NMPA breaking news and regulatory updates for BD, investors, and analysts

Showing 1–12 of 48 articles

High impact NewsJun 10, 2026

PMDA approves ENHERTU for HER2-low breast cancer in Japan

5 min

Dr. Yuki Tanaka
High impact NewsJun 3, 2026

Datroway Approved: A New Hope for Metastatic TNBC Patients

FDA · metastatic TNBC · 5 min

Dr. Yuki Tanaka
High impact NewsJun 2, 2026

China's Ascendancy in Oncology Research Alarms European Oncologists, Threatening Europe's Competitive Edge

oncology · 9 min

Dr. Yuki Tanaka
High impact NewsJun 2, 2026

ASCO 2026: Asian Oncology Innovation Takes Center Stage, Driving Global Clinical Trial Advancements

oncology · 6 min

Dr. Yuki Tanaka
Medium impact NewsMay 31, 2026

Innovative Oncology Pharma Companies in China: A Look Ahead

oncology · 2 min

Dr. Yuki Tanaka
Medium impact NewsMay 31, 2026

Biomarkers and Digital Technologies Transforming Oncology in Asia

oncology · 2 min

Dr. Yuki Tanaka
Medium impact NewsMay 31, 2026

UK Clinical Trials in Oncology: Actions Driving Impact

oncology · 3 min

Dr. Yuki Tanaka
Medium impact NewsMay 30, 2026

Clinical Trials Market in Oncology: Size and Growth Insights for 2034

oncology · 2 min

Dr. Yuki Tanaka
Medium impact NewsMay 30, 2026

Innovent Biologics and Pfizer: A $10.5B Oncology Partnership

oncology · 2 min

Dr. Yuki Tanaka
Medium impact NewsMay 29, 2026

Medical Advances Soar With APAC's Clinical Trial Growth in Oncology

oncology · 2 min

Dr. Yuki Tanaka
Medium impact NewsMay 28, 2026

Nuance Pharma Secures IND Clearance for Actair® in China

oncology · 2 min

Dr. Yuki Tanaka
Medium impact NewsMay 27, 2026

Lundbeck Secures Korean Approval for Vyepti: Implications for Oncology and Migraine Treatment

Korean · oncology · 3 min

Dr. Yuki Tanaka